Ponsegromab for the Treatment of Cancer Cachexia
Sep 23, 2024 · 1. Ponsegromab at increasing doses resulted in a mean increase in body weight compared to placebo; 1.22 kg (2.21%) in the 100-mg group, 1.92 kg (2.99%) in the 200-mg …
Tulisokibart effectively induces clinical remission in moderately to ...
Oct 3, 2024 · 1. In this randomized controlled trial, among patients with moderately to severely active ulcerative colitis, tulisokibart, a monoclonal antibody directed against TL1A, more …
Fosrolapitant/Palonosetron in Chemotherapy-Induced Nausea and …
Dec 9, 2024 · 1. The complete response rate at the overall phase in cycle 1 was 77.7% vs 78.2% with treatment vs control groups (significant for noninferiority). 2. Treatment-related adverse …
Landmark Trials & Summaries: The Classics in Medicine - 2 Minute …
Title Year Journal Citations Key findings; The UKPDS: Reducing the risk of diabetes-related morbidity and mortality: 1998: Lancet: 20,000: 1. For patients with type 2 diabetes mellitus, …
#VisualAbstract: Antibiotic Treatment for 7 is Noninferior to 14 …
Dec 2, 2024 · 2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who …
RAMOSE Phase II trial finds promising results for osimertinib and ...
Dec 10, 2024 · 1. Treatment of patients with tyrosine kinase inhibitor (TKI)-naïve epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) with osimertinib …
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
Dec 16, 2024 · 1. Median progression-free survival was 9.4 months in the imlunestrant–abemaciclib group vs 5.5 months in the imlunestrant group with HR 0.57 …
Impact of dialysis on survival and home time among older adults …
Aug 25, 2024 · In-Depth [retrospective cohort]: This retrospective cohort study was designed to emulate a randomized trial comparing dialysis versus medical management in older patients …
Endometriosis and uterine fibroids associated with a greater risk of ...
Nov 29, 2024 · 1. A history of endometriosis and uterine fibroids in women was associated with a greater risk of premature mortality and mortality due to gynecological cancers. 2. A history of …
Pressure-mediated biofeedback with pelvic floor muscle training …
Nov 16, 2024 · 1. In this randomized clinical trial comparing the use of pelvic floor muscle training (PFMT) alone to PFMT with a biofeedback (BF) device, the use of PFMT with BF was superior …